New Delhi: Dr Reddy's Laboratories on Tuesday announced the launch of a nivolumab biosimilar, expanding its portfolio of immune-targeting cancer treatments in the country.NIVORZ, a biosimilar to Opdivo (nivolumab), ...
IMAGE: Kindly note that this image has been posted for representational purposes only. Photograph: ANI Photo Citing public interest, the Delhi high court has cleared the way for Zydus ...